疫苗前沿 | 辉瑞:第三剂新冠疫苗提高中和抗体滴度5-8倍
2021-07-30
预防界.
参考资料:
[1] PFIZER REPORTS SECOND-QUARTER 2021 RESULTS. Retrieved July 28, 2021, from https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-PFE-Earnings-Release.pdf
[2] Second Quarter 2021 Earnings Teleconference. Retrieved July 28, 2021, from https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf
[3] Thomas et al., (2021). Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. medRxiv, : https://doi.org/10.1101/2021.07.28.21261159
不感兴趣
看过了
取消
药明康德,mRNA,疫苗,新冠,滴度,辉瑞,抗体
不感兴趣
看过了
取消
精彩评论
相关阅读
赞+1